These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15776505)

  • 1. Zetia and Zocor: good together? New combo pill Vytorin may help some reach low LDL goals.
    Harv Health Lett; 2005 Feb; 30(4):3. PubMed ID: 15776505
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
    Galin ID; Smith DA
    Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
    Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaching target LDL cholesterol has become more affordable with launch of ezetimibe/simvastatin combination in South Africa.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(5):291. PubMed ID: 20972520
    [No Abstract]   [Full Text] [Related]  

  • 5. Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.
    Lyseng-Williamson KA
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):49-56. PubMed ID: 22208355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
    Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS
    Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
    Huang JC; Lee TY; Liou MJ; Lin CM; Pei D; Chen ZC; Liu RT; Kwok CF
    Curr Med Res Opin; 2011 Aug; 27(8):1645-51. PubMed ID: 21699369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?
    Doggrell SA
    Expert Opin Pharmacother; 2012 Jul; 13(10):1469-80. PubMed ID: 22725704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
    Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vytorin: a combination of ezetimibe and simvastatin.
    Med Lett Drugs Ther; 2004 Sep; 46(1191):73-4. PubMed ID: 15365507
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: Clinical benefits of ezetimibe: absence of proof is just that.
    Doggrell SA
    Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
    Spence JD
    Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
    Gouni-Berthold I; Mikhailidis DP; Rizzo M
    Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lowering cholesterol becomes easier. Combining instead of increasing dosage].
    MMW Fortschr Med; 2003 Jan; 145(3-4):59. PubMed ID: 12619241
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
    Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.